SCHEMBL8086349

SCHEMBL8086349

COC(=O)c1ccc(OCC(=O)c2cc3c(cc2Br)C(C)(C)CCC3)c(I)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.45
RXRA P19793 4/20 0.40
RXRB P28702 2/20 0.40
RXRG P48443 2/20 0.40
CYP26A1 O43174 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 5/20 0.36
TDP1 Q9NUW8 1/20 0.36
NPC1 O15118 4/20 0.35
CYP26B1 Q9NR63 1/20 0.35
TP53 P04637 1/20 0.35
MAPK1 P28482 1/20 0.35
MGLL Q99685 1/20 0.35
ATM Q13315 1/20 0.35
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 3/20 0.33
HTT P42858 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8099280 0.91 RXRA (0.43) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL7802944 0.91 RXRA (0.48) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL8101865 0.87 CYP3A4 (0.54) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL7799981 0.82 RXRA (0.51) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL8099423 0.81 CYP3A4 (0.43) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL8093197 0.79 CYP3A4 (0.54) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL7802940 0.77 CYP26A1 (0.53) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL6733878 0.76 CYP3A4 (0.71) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL8086450 0.71 CYP3A4 (0.47) CYP3A4RXRARXRBRXRGCYP26A1
SCHEMBL7801863 0.71 RXRA (0.48) CYP3A4RXRARXRBRXRGCYP26A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6030952-A AS HUMAN AND VETERINARY MEDICINE, PARTICULARLY IN THE TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHTHALMOLOGIC CONDITIONS, AND IN COSMETIC COMPOSITIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES GALDERMA (FR) 2000-02-29 US disclosed